Cargando…
Predictive biomarkers for 5‐ALA‐PDT can lead to personalized treatments and overcome tumor‐specific resistances
BACKGROUND: Photodynamic therapy (PDT) is a minimally invasive, clinically approved therapy with numerous advantages over other mainstream cancer therapies. 5‐aminolevulinic acid (5‐ALA)‐PDT is of particular interest, as it uses the photosensitiser PpIX, naturally produced in the heme pathway, follo...
Autores principales: | Mastrangelopoulou, Maria, Grigalavicius, Mantas, Raabe, Tine H., Skarpen, Ellen, Juzenas, Petras, Peng, Qian, Berg, Kristian, Theodossiou, Theodossis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780429/ https://www.ncbi.nlm.nih.gov/pubmed/32737955 http://dx.doi.org/10.1002/cnr2.1278 |
Ejemplares similares
-
5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action
por: Grigalavicius, Mantas, et al.
Publicado: (2022) -
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy
por: Theodossiou, Theodossis A., et al.
Publicado: (2019) -
Reactive Species from Two-Signal Activated Macrophages Interfere with Their Oxygen Consumption Measurements
por: Christopoulos, Panagiotis F., et al.
Publicado: (2021) -
Proton-dynamic therapy following photosensitiser activation by accelerated protons demonstrated through fluorescence and singlet oxygen production
por: Grigalavicius, M., et al.
Publicado: (2019) -
Publisher Correction: Proton-dynamic therapy following photosensitiser activation by accelerated protons demonstrated through fluorescence and singlet oxygen production
por: Grigalavicius, M., et al.
Publicado: (2021)